Serum Institute of India to develop vaccine for Mpox
Pune: The Serum Institute of India (SII) has announced that the company is developing a vaccine to address the risks ...
Pune: The Serum Institute of India (SII) has announced that the company is developing a vaccine to address the risks ...
Serum Institute of India (SII) CEO Adar Poonawalla has sought regulatory approval to establish his Poonawalla Vision Fund to invest ...
After Covishield, the Serum Institute of India (SII) has begun the production of Covovax. US biotechnology company Novavax’s protein-based Covid-19 ...